Kidney Cancer Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

PDIGREE Trial in Metastatic Untreated RCC
Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the design on the outcomes of the PDIGREE trial in metastatic, untreated renal cell carcinoma. Author: obr Added: 07/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Agents in the 2nd Line Setting in RCC
Nancy A. Dawson MD, Professor of Medicine at Lombardi Cancer Center elaborates on the preferred agents on the 2nd line setting of renal cell carcinoma if a patient progresses on pembrolizumab/axitinib... Author: obr Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 26, 2019 Category: Cancer & Oncology Source Type: podcasts

In the Treatment of 1st Line RCC: Selecting the Appropriate I-O and TKI combination
Nancy A. Dawson MD, Professor of Medicine at Lombardi Cancer Center shares on how to decide between combinations of immuno-oncology (I-O) and TKIs for treating 1st line renal cell carcinoma (RCC). Author: obr Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 26, 2019 Category: Cancer & Oncology Source Type: podcasts

Updates On Sarcomatoid & Rhabdoid Renal Cell Carcinoma: Immune Checkpoint Inhibitors Are Doing Really Well In Sarcomatoid RCC
Ziad Bakouny MD @ZiadBakouny Of Dana-Farber Cancer Institute Discusses Updates On Sarcomatoid & Rhabdoid Renal Cell Carcinoma: Immune Checkpoint Inhibitors Are Doing Really Well In Sarcomatoid RCC. Author: Annual-Meeting Added: 06/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A+Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).
 Toni Choureiri, MD, discusses the biomarker analyses from JAVELIN Renal 101. Background: The phase 3 JAVELIN Renal 101 trial in previously untreated patients (pts) with aRCC demonstrated a progre... Author: Annual-Meeting Added: 06/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Neoadjuvant Trials In Kidney Cancer
Jose Karam M.D., FACS Associate Professor in the Department of Urology at The University of Texas MD Anderson Cancer Center in Houston, Texas Discusses Neoadjuvant Trials In Kidney Cancer. At The Four... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Surgery Or Therapy First
Axel Bex M.D. Department of Urology The Netherlands Cancer Institute Amsterdam Discusses Surgery Or Therapy First. At The Fourteenth European International Kidney Cancer Symposium on Mar 29, 2019. Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Elaborating On The CARMENA Trial
Axel Bex M.D. Department of Urology The Netherlands Cancer Institute Amsterdam Discusses Elaborating On The CARMENA Trial. At The Fourteenth European International Kidney Cancer Symposium on Mar 2... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Discussing Perioperative Therapy In The CARMENA & PROBE Trials
Axel Bex M.D. Department of Urology The Netherlands Cancer Institute Amsterdam Discusses Perioperative Therapy In The CARMENA & PROBE Trials. At The Fourteenth European International Kidney Cancer... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Why One Year Of Treatment With Dosing Of Drugs
Grant Stewart PhD an academic surgeon at the University of Cambridge Discusses Why One Year Of Treatment With Dosing Of Drugs. At The Fourteenth European International Kidney Cancer Symposium on Mar 2... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Elaborating On Multiple Kidney Cancer Studies
Grant Stewart PhD an academic surgeon at the University of Cambridge Discusses Elaborating On Multiple Kidney Cancer Studies. At The Fourteenth European International Kidney Cancer Symposium on Mar 29... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Discussing Two IO Plus TKI Studies In Kidney Cancer
Grant Stewart PhD an academic surgeon at the University of Cambridge Discusses Two IO Plus TKI Studies In Kidney Cancer. At The Fourteenth European International Kidney Cancer Symposium on Mar 29, 201... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

When Can cfDNA Profiling Be Applicable
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses When Can cfDNA Profiling Be Applicable. At The Fourteenth E... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts